Clinical Trials Directory

Trials / Sponsors / Tranzyme, Inc.

Tranzyme, Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
TerminatedDiabetic Gastroparesis Efficacy/Safety Study of TZP-102
Diabetic Gastroparesis
Phase 22012-08-01
CompletedAffects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gas
Gastroparesis, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Phase 22011-09-01
CompletedPatient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
Diabetes Mellitus, Gastroparesis
—2011-03-01
CompletedUlimorelin Study of Efficacy and Safety (ULISES 008)
Gastrointestinal Dysmotility
Phase 32011-02-01
CompletedUlimorelin Study of Efficacy and Safety (ULISES 007)
Gastrointestinal Dysmotility
Phase 32011-01-01
CompletedSafety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes
Gastroparesis, Diabetes Mellitus
Phase 22009-04-01
CompletedSafety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastrop
Gastroparesis, Diabetes Mellitus
Phase 22007-10-01
CompletedSafety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery
Postoperative Ileus
Phase 22007-07-01
CompletedSafety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis
Gastroparesis, Diabetes Mellitus
Phase 12006-08-01